Factor IX inhibitors and anaphylaxis in haemophilia B

被引：6
|
作者：
Warrier, I
Ewenstein, BM
Koerper, MA
Shapiro, A
Key, N
Dimichele, D
Miller, RT
Pasi, J
Rivard, GE
Sommer, SS
Bergmann, F
Lusher, JM
机构：
[1] WAYNE STATE UNIV,DETROIT,MI 48201
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
[3] BRIGHAM & WOMENS HOSP,BOSTON,MA 02115
[4] UNIV CALIF SAN FRANCISCO,MED CTR,SAN FRANCISCO,CA 94143
[5] JAMES WHITCOMB RILEY HOSP CHILDREN,INDIANAPOLIS,IN 46202
[6] UNIV MINNESOTA,HOSP & CLIN,MINNEAPOLIS,MN 55455
[7] CORNELL UNIV,MED CTR,NEW YORK HOSP,NEW YORK,NY 10021
[8] CHILDRENS HOSP LOS ANGELES,LOS ANGELES,CA 90027
[9] ROYAL FREE HOSP,LONDON NW3 2OG,ENGLAND
[10] HOSP ST JUSTINE,MONTREAL,PQ,CANADA
[11] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
[12] HANNOVER MED SCH,DEPT PEDIAT,D-3000 HANNOVER,GERMANY
来源：
HAEMOPHILIA | 1996年 / 2卷 / 04期
关键词：
D O I：
10.1111/j.1365-2516.1996.tb00149.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 260
页数：2
相关论文
共 50 条
  • [1] Factor IX inhibitors and anaphylaxis in hemophilia B
    Warrier, I
    Ewenstein, BM
    Koerper, MA
    Shapiro, A
    Key, N
    DiMichele, D
    Miller, RT
    Pasi, J
    Rivard, GE
    Sommer, SS
    Katz, J
    Bergmann, F
    Ljung, R
    Petrini, P
    Lusher, JM
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (01) : 23 - 27
  • [2] Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX
    Barnes, C.
    Davis, A.
    Furmedge, J.
    Egan, B.
    Donnan, L.
    Monagle, P.
    HAEMOPHILIA, 2010, 16 (05) : 840 - 841
  • [3] Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China
    Dou, Xueqing
    Zhang, Wenhui
    Poon, Man-Chiu
    Zhang, Xinsheng
    Wu, Runhui
    Feng, Xiaoqin
    Yang, Linhua
    Cheng, Peng
    Chen, Shu
    Wang, Ying
    Zhou, Hu
    Huang, Meijuan
    Song, Yanping
    Jin, Chenghao
    Zhang, Donglei
    Chen, Lingling
    Liu, Wei
    Zhang, Lei
    Xue, Feng
    Yang, Renchi
    HAEMOPHILIA, 2023, 29 (01) : 123 - 134
  • [4] Management of haemophilia B patients with inhibitors and anaphylaxis
    Warrier, I
    HAEMOPHILIA, 1998, 4 (04) : 574 - 576
  • [5] New strategy for the treatment of factor IX inhibitors in severe haemophilia B.
    Wermes, C
    Prondzinski, MVD
    Welte, K
    Sykora, KW
    BLOOD, 2000, 96 (11) : 267A - 267A
  • [6] IGG SUBCLASS IDENTIFICATION OF INHIBITORS TO FACTOR-IX IN HAEMOPHILIA-B PATIENTS
    ORSTAVIK, KH
    MILLER, CH
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (04) : 451 - 454
  • [7] Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B
    Saini, Surbhi
    Croteau, Stacy E.
    Horling, Frank M.
    Dunn, Amy L.
    HAEMOPHILIA, 2019, 25 (02) : E126 - E129
  • [8] Eradication of factor IX neutralizing and anaphylactic inhibitors in a patient with severe haemophilia B using cyclophosphamide immune suppression and factor IX desensitization
    Greenmyer, Jacob R.
    Grindeland, Carlina J.
    Kobrinsky, Nathan L.
    HAEMOPHILIA, 2020, 26 (02) : E51 - E54
  • [9] Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review
    Miller, C. H.
    HAEMOPHILIA, 2018, 24 (02) : 186 - 197
  • [10] COST-EFFECTIVENESS OF RECOMBINANT FACTOR IX FC PROPHYLAXIS AND RECOMBINANT FACTOR IX ONDEMAND TREATMENT IN PATIENTS WITH HAEMOPHILIA B WITHOUT INHIBITORS
    Pochopien, M.
    Tytula, A.
    Toumi, M.
    Falk, A.
    Cioni, L.
    Hakimi, Z.
    Eriksson, D.
    VALUE IN HEALTH, 2022, 25 (12) : S73 - S74
12345